Is Boston Scientific Corporation (BSX) a Buy, Sell, or Hold?
NYSE : BSX
Boston Scientific Corporation — Institutional Ownership
$46.73 USD
$0.73 (1.59%)
- Volume
- 18.67M
- Average Volume
- 20.9M
- Market Capitalization
- $69.46B
- P/E Ratio
- 18.84
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $109.50
- Year Low
- $42.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.90
Institutional Ownership Summary
Institutional Ownership %
4.38%
Investors Holding
540
change: -1210 | last: 1750
Increased Positions
247
change: -605 | last: 852
Reduced Positions
229
change: -417 | last: 646
New Positions
55
change: -143 | last: 198
Sold Positions
1186
change: 869 | last: 317
Total Calls
54100
Total Puts
15000
Put-Call Ratio
0.28
change: -9.2059 | last: 0.3693
Total Invested
2.77B
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-06 | FMR LLC | 75.84M | 5.10% |
| 2026-04-29 | Vanguard Capital Management | 111.13M | 7.47% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2025-08-06 | FMR LLC | 110.32M | 7.50% |
| 2025-04-17 | BlackRock, Inc. | 113.01M | 7.60% |
| 2025-04-07 | FMR LLC | 141.15M | 9.60% |
| 2022-02-10 | Boston Scientific Corporation | 543.97K | 8.00% |
| 2022-02-09 | FMR LLC | 100.08M | 7.02% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 111.62M | 7.83% |
| 2022-02-09 | Abigail P. Johnson | 100.08M | 7.02% |
| 2022-02-08 | (1) BlackRock, Inc. | 127.92M | 9.00% |
| 2022-02-04 | Wellington Group Holdings LLP | 74.42M | 5.22% |
| 2022-02-04 | Wellington Investment Advisors Holdings LLP | 74.42M | 5.22% |
| 2022-02-04 | Wellington Management Group LLP | 74.42M | 5.22% |
| 2022-02-03 | Boston Scientific Corporation | - | 36.00% |
| 2022-02-02 | 04-2747644 | 5.0 | 6.10% |
| 2021-02-16 | 95-1411037 | 13.0 | 0.50% |
| 2021-02-12 | Boston Scientific Corporation | 5.99M | 16.80% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 110.78M | 7.74% |
| 2021-02-08 | FMR LLC | 65.41M | 4.57% |
| 2021-02-08 | Abigail P. Johnson | 65.41M | 4.57% |
| 2021-02-05 | (1) BlackRock, Inc. | 135.96M | 9.50% |
| 2021-02-04 | Wellington Management Group LLP | 77.27M | 5.40% |
| 2021-02-04 | Wellington Investment Advisors Holdings LLP | 77.27M | 5.40% |
| 2021-02-04 | Wellington Group Holdings LLP | 77.27M | 5.40% |
| 2020-02-14 | Capital World Investors ** | 108.07M | 7.70% |
| 2020-02-12 | The Vanguard Group - 23-1945930 | 109.02M | 7.82% |
| 2020-02-07 | FMR LLC | 127.51M | 9.15% |
| 2020-02-07 | Abigail P. Johnson | 127.51M | 9.15% |
| 2020-02-05 | (1) BlackRock, Inc. | 101.6M | 7.30% |
| 2019-02-14 | Capital World Investors ** | 100.15M | 7.20% |
| 2019-02-13 | FMR LLC | 152.51M | 11.02% |
| 2019-02-13 | Abigail P. Johnson | 152.51M | 11.02% |
| 2019-02-12 | Wellington Investment Advisors Holdings LLP | 63.23M | 4.57% |
| 2019-02-12 | Wellington Management Group LLP | 63.23M | 4.57% |
| 2019-02-12 | Wellington Group Holdings LLP | 63.23M | 4.57% |
| 2019-02-04 | (1) BlackRock, Inc. | 116.51M | 8.40% |
| 2018-02-13 | FMR LLC | 157.52M | 11.47% |
| 2018-02-13 | Abigail P. Johnson | 157.52M | 11.47% |
| 2018-02-08 | Wellington Management Group LLP | 73.82M | 5.38% |
| 2018-02-08 | Wellington Group Holdings LLP | 73.82M | 5.38% |
| 2018-02-08 | Wellington Investment Advisors Holdings LLP | 73.82M | 5.38% |
| 2018-01-29 | (1) BlackRock, Inc. | 97.78M | 7.10% |
| 2017-02-14 | FMR LLC | 171.6M | 12.60% |
| 2017-02-14 | Abigail P. Johnson | 171.6M | 12.60% |
| 2017-02-09 | Wellington Management Group LLP | 69.59M | 5.11% |
| 2017-02-09 | Wellington Group Holdings LLP | 69.59M | 5.11% |
| 2017-02-09 | Wellington Investment Advisors Holdings LLP | 69.59M | 5.11% |
| 2017-01-19 | (1) BlackRock, Inc. | 96.49M | 7.10% |
| 2016-02-12 | Abigail P. Johnson | 172.23M | 12.80% |
| 2016-02-12 | FMR LLC | 172.23M | 12.80% |
| 2016-02-11 | Wellington Investment Advisors Holdings LLP | 94.74M | 7.04% |
| 2016-02-11 | Wellington Management Group LLP | 94.74M | 7.04% |
| 2016-02-11 | Wellington Group Holdings LLP | 94.74M | 7.04% |
| 2016-02-11 | Wellington Management Company LLP | 92.66M | 6.89% |
| 2016-02-10 | (1) BlackRock, Inc. | 96.39M | 7.20% |
| 2015-10-26 | JPMorgan Chase & Co. | 35.01M | 2.60% |
| 2015-02-13 | Abigail P. Johnson | 198.97M | 15.00% |
| 2015-02-13 | Edward C. Johnson 3d | 198.97M | 15.00% |
| 2015-02-13 | FMR LLC | 198.97M | 15.00% |
| 2014-02-14 | 04-2683227 | 48.31M | 3.62% |
| 2014-02-14 | Edward C. Johnson 3d | 180.25M | 13.50% |
| 2014-02-14 | FMR LLC | 180.25M | 13.50% |
| 2014-02-11 | LOUIS M. BACON | 1.99M | 5.08% |
| 2014-01-28 | (1) BlackRock, Inc. | 84.81M | 6.40% |
| 2013-07-10 | Edward C. Johnson 3d | 141.18M | 10.47% |
| 2013-07-10 | FMR LLC | 141.18M | 10.47% |
| 2013-02-14 | 04-2683227 | 71.19M | 5.19% |
| 2013-01-30 | (1) BlackRock, Inc. | 83.96M | 6.12% |
| 2012-08-09 | (1) BlackRock, Inc. | 73.98M | 4.81% |
| 2011-11-10 | Capital Research Global Investors ** | 70.77M | 4.60% |
| 2011-02-10 | (1) BlackRock, Inc. | 75.07M | 4.94% |
| 2011-02-03 | (1) BlackRock, Inc. | 80.53M | 5.30% |
| 2010-10-12 | PRIMECAP Management Company 95-3868081 | 70.94M | 4.68% |
| 2010-08-10 | Capital Research Global Investors ** | 152.18M | 10.00% |
| 2010-01-29 | BlackRock for purposes of Schedule 13G filings. | 75.87M | 5.02% |
| 2009-02-11 | Dodge & Cox 94-1441976 | 87.61M | 5.80% |
| 2008-04-25 | Scientific Corporation | 368.19K | 2.80% |
| 2008-04-25 | Scientific Scimed, Inc. | 368.19K | 2.80% |
| 2008-02-13 | Dodge & Cox 94-1441976 | 79.2M | 5.30% |
| 2006-02-03 | ( | 253.51M | 30.94% |
| 2005-08-17 | Boston Scientific Corporation | 22.57M | 13.20% |
| 2004-02-17 | Edward C. Johnson 3d | 37.87M | 4.60% |
| 2004-02-17 | FMR Corp. | 37.87M | 4.60% |
| 2004-02-17 | Abigail P. Johnson | 37.87M | 4.60% |
| 2003-08-11 | Edward C. Johnson 3d | 20.61M | 5.03% |
| 2003-08-11 | Abigail P. Johnson | 20.61M | 5.03% |
| 2003-08-11 | FMR Corp. | 20.61M | 5.03% |
| 2003-06-09 | 04-2695240 | 2.08M | 9.32% |
| 2003-02-13 | Abigail P. Johnson | 42.21M | 10.35% |
| 2003-02-13 | FMR Corp. | 42.21M | 10.35% |
| 2003-02-13 | Edward C. Johnson 3d | 42.21M | 10.35% |
| 2002-11-12 | Abigail P. Johnson | 40.82M | 10.03% |
| 2002-11-12 | FMR Corp. | 40.82M | 10.03% |
| 2002-11-12 | Edward C. Johnson 3d | 40.82M | 10.03% |
| 2002-02-12 | 943112180 | 23.47M | 5.82% |
| 2002-02-12 | Barclays Global Fund Advisors | 2.01M | 0.50% |
| 2002-02-12 | Barclays Capital Securities, Ltd. | 2200.0 | 0.00% |
| 2002-02-12 | Barclays Funds Limited | 63438.0 | 0.02% |
| 2002-02-12 | Barclays Global Investors, LTD. | 1.55M | 0.39% |
| 2002-02-12 | Barclays Life Assurance Company, Ltd. | 18976.0 | 0.00% |
| 2002-02-12 | Barclays Trust and Banking Company (Japan), Ltd. | 99178.0 | 0.02% |
| 1999-02-18 | The Abele Children's Irrevocable Trust Dated October 29, 1979 | 35.74M | 9.10% |
| 1998-02-13 | EIN #84-0964425 | - | 0.00% |
| 1998-02-13 | Boston Scientific Corporation | 501K | 5.40% |
| 1998-02-13 | Boston Scientific Corporation | 587.5K | 5.40% |
| 1998-02-13 | EIN #84-0765359 | - | 0.00% |
| 1998-02-13 | John E. Abele | 14.83M | 7.60% |
| 1998-02-13 | Thomas H. Bailey | - | 0.00% |
| 1996-02-12 | ###-##-####) | 4.18M | 2.76% |
| 1996-02-12 | 04-2507163) | 4.18M | 2.76% |
| 1996-02-12 | ###-##-####) | 4.18M | 2.76% |
| 1995-02-09 | 04-2507163) | 8.43M | 8.69% |
| 1995-02-09 | ###-##-####) | 8.43M | 8.69% |
BSX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $95.35 | 1.48B | $141.16B | $2.04B | $12.42B | $151.53B |
| 2024-12-31 | $89.32 | 1.47B | $131.43B | $414M | $11.15B | $142.17B |
| 2023-12-31 | $57.81 | 1.45B | $84B | $865M | $9.49B | $92.62B |
| 2022-12-31 | $46.27 | 1.43B | $66.19B | $928M | $9.28B | $74.54B |
| 2021-12-31 | $42.48 | 1.42B | $60.42B | $1.92B | $9.45B | $67.95B |
| 2020-12-31 | $35.95 | 1.42B | $50.93B | $1.73B | $9.54B | $58.74B |
| 2019-12-31 | $45.22 | 1.39B | $62.92B | $217M | $10.28B | $72.98B |
| 2018-12-31 | $35.34 | 1.38B | $48.8B | $146M | $7.03B | $55.69B |
| 2017-12-31 | $24.79 | 1.37B | $33.96B | $188M | $5.58B | $39.35B |
| 2016-12-31 | $21.63 | 1.36B | $29.36B | $196M | $5.48B | $34.65B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42.68 | 1.48B | $63.06B | -$ | -$ | $63.06B |
| 2026-03-31 | $62.75 | 1.48B | $93.18B | $1.52B | $11.03B | $102.68B |
| 2025-12-31 | $95.35 | 1.48B | $141.38B | $2.04B | $12.42B | $151.75B |
| 2025-09-30 | $97.63 | 1.48B | $144.66B | $1.28B | $12.05B | $155.43B |
| 2025-06-30 | $107.41 | 1.48B | $158.81B | $534M | $12.03B | $170.3B |
| 2025-03-31 | $100.88 | 1.48B | $149.02B | $725M | $11.71B | $160B |
| 2024-12-31 | $89.32 | 1.47B | $131.68B | $414M | $11.15B | $142.41B |
| 2024-09-30 | $83.80 | 1.47B | $123.41B | $2.5B | $11.26B | $132.17B |
| 2024-06-30 | $76.41 | 1.47B | $112.37B | $2.91B | $10.94B | $120.39B |
| 2024-03-31 | $68.10 | 1.47B | $100B | $2.33B | $11B | $108.67B |
| 2023-12-31 | $57.81 | 1.47B | $84.71B | $865M | $9.49B | $93.34B |
| 2023-09-30 | $52.80 | 1.46B | $77.33B | $952M | $9.3B | $85.67B |